Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
EVALUATION OF RESPONSE TO SECOND LINE THERAPY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND INADEQUATE RESPONSE TO UDCA: A PILOT STUDY OF LIVER BIOPSIES FOLLOW UP
Alejandra Villamil; Daniela de la Viña; Eduardo Mullen; Ignacio Lucero; Juan Carlos Bandi;
Ann Hepatol. 2025;30 Supl 2:
O-32 FULMINANT AUTOIMMUNE HEPATITIS: CLINICAL PRESENTATION, OUTCOME AND PROGNOSTIC FACTORS.
Alejandra Villamil; Marlene Padilla; Eduardo Mullen; Juan Carlos Bandi; Gabriel Carballo; Natalia Sobenko; Sebastian Marciano;
Ann Hepatol. 2023;28 Supl 1:
ANTIPHOSPHOLIPID ANTIBODIES ASSOCIATED VASCULAR EVENTS ARE AN UNDERRECOGNIZED CAUSE OF MORBIDITY AND MORTALITY AFTER LIVER TRANSPLANTATION: BENEFIT OF PLASMAPHERESIS AND ANTICOAGULATION IN TRANSPLANTED PATIENTS WITH HIGH THROMBOTIC RISK
Sofía Tejada; Walter González; Eduardo De Santibañes; Ignacio Lucero; Juan Carlos Bandi; Alejandra Villamil;
Ann Hepatol. 2025;30 Supl 2: